Segall Bryant & Hamill’s Anixa Biosciences ANIX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-17,400
| Closed | -$55.7K | – | 519 |
|
2023
Q2 | $55.7K | Hold |
17,400
| – | – | ﹤0.01% | 700 |
|
2023
Q1 | $74K | Hold |
17,400
| – | – | ﹤0.01% | 706 |
|
2022
Q4 | $73K | Hold |
17,400
| – | – | ﹤0.01% | 705 |
|
2022
Q3 | $86K | Hold |
17,400
| – | – | ﹤0.01% | 713 |
|
2022
Q2 | $53K | Hold |
17,400
| – | – | ﹤0.01% | 719 |
|
2022
Q1 | $48K | Hold |
17,400
| – | – | ﹤0.01% | 739 |
|
2021
Q4 | $52K | Hold |
17,400
| – | – | ﹤0.01% | 592 |
|
2021
Q3 | $83K | Hold |
17,400
| – | – | ﹤0.01% | 773 |
|
2021
Q2 | $68K | Hold |
17,400
| – | – | ﹤0.01% | 759 |
|
2021
Q1 | $82K | Hold |
17,400
| – | – | ﹤0.01% | 806 |
|
2020
Q4 | $53K | Hold |
17,400
| – | – | ﹤0.01% | 730 |
|
2020
Q3 | $43K | Hold |
17,400
| – | – | ﹤0.01% | 703 |
|
2020
Q2 | $53K | Hold |
17,400
| – | – | ﹤0.01% | 769 |
|
2020
Q1 | $27K | Hold |
17,400
| – | – | ﹤0.01% | 776 |
|
2019
Q4 | $57K | Hold |
17,400
| – | – | ﹤0.01% | 810 |
|
2019
Q3 | $70K | Hold |
17,400
| – | – | ﹤0.01% | 809 |
|
2019
Q2 | $64K | Hold |
17,400
| – | – | ﹤0.01% | 804 |
|
2019
Q1 | $79K | Hold |
17,400
| – | – | ﹤0.01% | 809 |
|
2018
Q4 | $69K | Hold |
17,400
| – | – | ﹤0.01% | 806 |
|
2018
Q3 | $81K | Hold |
17,400
| – | – | ﹤0.01% | 832 |
|
2018
Q2 | $53K | Buy |
+17,400
| New | +$53K | ﹤0.01% | 847 |
|